Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabino De Placido

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Future Oncology (London, England)|September 19, 2014
Treatment options in HR⁺/HER2⁻ advanced breast cancer patients pretreated with nonsteroidal aromatase inhibitors: what does current evidence tell us?Sabino De Placido, Paolo Pronzato
Future Oncology (London, England)|December 18, 2013
Using cumulative toxicity to identify the optimal second-line targeted therapy in patients with metastatic renal cell carcinoma: what's new?Giuseppe Di Lorenzo, Sabino De Placido
Cell and Tissue Banking|June 7, 2012
Issues of banking breast cancer cells to generate mammospheresBianca Maria Veneziani, Sabino De Placido
Breast (Edinburgh, Scotland)|July 7, 2015
Features of aggressive breast cancerGrazia Arpino, Monica Milano, Sabino De Placido
Virchows Archiv : an International Journal of Pathology|February 13, 2019
Recent success and limitations of immune checkpoint inhibitors for cancer: a lesson from melanomaMargaret Ottaviano, Sabino De Placido, Paolo Antonio Ascierto
Anti-Cancer Drugs|August 14, 2014
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case studyGrazia Arpino, Sabino De Placido, Carmine De Angelis
Anti-Cancer Drugs|October 24, 2014
Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuationGiuseppe Di Lorenzo, Carlo Buonerba, Sabino de Placido
Current Opinion in Oncology|September 24, 2015
Targeting fibroblast growth factor receptor pathway in breast cancerCarmen Criscitiello, Angela Esposito, Sabino De Placido, et al.
Cancer Treatment Reviews|September 26, 2016
Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectivesFrancesco Schettini, Mario Giuliano, Sabino De Placido, et al.
Expert Opinion on Drug Discovery|October 5, 2016
Approaches for targeting cancer stem cells drug resistanceRoberta Rosa, Valentina D'Amato, Sabino De Placido, et al.
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Future Oncology (London, England)|September 19, 2014
Treatment options in HR⁺/HER2⁻ advanced breast cancer patients pretreated with nonsteroidal aromatase inhibitors: what does current evidence tell us?Sabino De Placido, Paolo Pronzato
Future Oncology (London, England)|December 18, 2013
Using cumulative toxicity to identify the optimal second-line targeted therapy in patients with metastatic renal cell carcinoma: what's new?Giuseppe Di Lorenzo, Sabino De Placido
Cell and Tissue Banking|June 7, 2012
Issues of banking breast cancer cells to generate mammospheresBianca Maria Veneziani, Sabino De Placido
Breast (Edinburgh, Scotland)|July 7, 2015
Features of aggressive breast cancerGrazia Arpino, Monica Milano, Sabino De Placido
Virchows Archiv : an International Journal of Pathology|February 13, 2019
Recent success and limitations of immune checkpoint inhibitors for cancer: a lesson from melanomaMargaret Ottaviano, Sabino De Placido, Paolo Antonio Ascierto
Anti-Cancer Drugs|August 14, 2014
Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case studyGrazia Arpino, Sabino De Placido, Carmine De Angelis
Anti-Cancer Drugs|October 24, 2014
Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuationGiuseppe Di Lorenzo, Carlo Buonerba, Sabino de Placido
Current Opinion in Oncology|September 24, 2015
Targeting fibroblast growth factor receptor pathway in breast cancerCarmen Criscitiello, Angela Esposito, Sabino De Placido, et al.
Cancer Treatment Reviews|September 26, 2016
Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectivesFrancesco Schettini, Mario Giuliano, Sabino De Placido, et al.
Expert Opinion on Drug Discovery|October 5, 2016
Approaches for targeting cancer stem cells drug resistanceRoberta Rosa, Valentina D'Amato, Sabino De Placido, et al.
Pageof 27